Investors Target Allergan After DOJ Price-Fixing Probe
A potential class of Allergan PLC shareholders on Tuesday told a New York federal court that the drugmaker and its executives failed to disclose that they were part of a scheme...To view the full article, register now.
Already a subscriber? Click here to view full article